-
Atrial Functional Substrates for the Prediction of Atrial Fibrillation Recurrence after Pulmonary Vein Isolation Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-12 Masaharu Masuda MD PhD, Yasuhiro Matsuda MD, Hiroyuki Uematsu MD, Mitsutoshi Asai MD PhD, Shin Okamoto MD, Takayuki Ishihara MD, Kiyonori Nanto MD, Takuya Tsujimura MD, Yosuke Hata MD, Naoko Higashino MD, Sho Nakao MD, Toshiaki Mano MD PhD
Low-voltage areas have been used as atrial structural substrates in estimating fibrotic degeneration in patients with atrial fibrillation (AF). The high-resolution maps obtained by recently developed mapping catheters allow the visualization of several functional abnormalities. We investigated the association between left atrial (LA) functional abnormal findings on a high-resolution substrate map and
-
Cardiovascular complications in young adults with Post-Acute Sequelae of COVID-19: a perspective from the United States Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-11 Jasninder Singh Dhaliwal MD, Nomesh Kumar MD, Sebastian Mactaggart, Hemamalini Sakthivel MD, Raheel Ahmed MBBS MRCP PGCME, Renuka Verma MD, Kamleshun Ramphul MD
-
Resting heart rate and incident atrial fibrillation in patients with diastolic dysfunction Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-09 Stefan Preisendörfer MD, Virginia Singla MD, Aditya Bhonsale MD, Krishna Kancharla MD, Floyd Thoma BS, Suresh Mulukutla MD, Andrew Voigt MD, Alaa Shalaby MD, N.A. Mark Estes MD, Sandeep Jain MD, Samir Saba MD
Diastolic dysfunction (DD) is associated with incident atrial fibrillation (AF). The influence of resting heart rate (RHR) on incident AF in patients with DD has not been investigated. The goal of this study is to assess the influence of RHR on incident AF in patients with DD. Patients from a large health system with no prior history of AF, a left ventricular ejection fraction ≥50% and documented DD
-
-
More than Meets the Eye: Defining the Prevalence, Pathophysiology, and Approach to Myocardial Iron Overload. Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-08 Lauren K. Truby MD MS, Katherine Michelis MD, Justin Grodin MD MPH
-
Unveiling the Hidden Stroke Threat in Patients with Atrial Fibrillation and Primary Hyperparathyroidism Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-06 Georges Khattar MD, Samer Asmar MD, Elie Bou Sanayeh MD MBA, Praneeth Keesari MD, Wissam Rahi MD, Fouad Sakr MD, Michel Khoury MD, Michael Cinelli DO, Samantha Lee MD, Mitchell Weinberg MD MBA, Marcin Kowalski MD MBA, Valay Parikh MD FACC FHRS
Recent ACC/AHA/ACCP/HRS guidelines suggest that patients with Atrial fibrillation (AF) at intermediate to low annual risk of ischemic stroke can benefit from consideration of factors that might modify their risk of stroke. The role of non-traditional risk factors such as primary hyperparathyroidism (PHPT) remains unexplored. In our study, we investigated the potential association between PHPT and the
-
Association of Serum Homocysteine with Peripheral Arterial Disease in Non-Diabetic Patients: A Study Based on National Health and Nutrition Examination Survey Database Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-06 Yi You M.M, Naxin Zeng B.S., Wengao Wu M.M, Boyang Liu M.M, Sheng Rong M.M, Dong Xu M.M
To investigate association of serum homocysteine (Hcy) levels with peripheral arterial disease (PAD) in non-diabetic patients based on data from National Health and Nutrition Examination Survey (NHANES). The study utilized data from three survey cycles (1999-2004) in NHANES database as the research dataset. Serum Hcy levels were considered as independent variable, while PAD was dependent variable.
-
A Curious Case of Left Ventricular Outflow Tract Velocity Time Integral Alternans With an Intra-Aortic Balloon Pump: Physiology in Action Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-06 Sumana Vardhan MD, Jonathan D. Moreno MD PhD
-
Nature of Neurological Complications and Outcome After Surgery For Type A Aortic Dissection Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-06 Fausto Biancari, Francesco Onorati, Sven Peterss, Joscha Buech, Giovanni Mariscalco, Javier Rodriguez Lega, Angel G. Pinto, Antonio Fiore, Andrea Perrotti, Amelié Hérve, Andreas Rukosujew, Till Demal, Lenard Conradi, Konrad Wisniewski, Marek Pol, Petr Kacer, Giuseppe Gatti, Enzo Mazzaro, Igor Vendramin, Daniela Piani, Mauro Rinaldi, Luisa Ferrante, Robert Pruna-Guillen, Dario Di Perna, Sebastien Gerelli
Surgery for type A aortic dissection (TAAD) is frequently complicated by neurological complications. The prognostic impact of neurological complications of different nature has been investigated in this study.
-
The burden of psychological trauma and post-traumatic stress disorder among adults with congenital heart disease: PTSD in ACHD Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-06 David J. Harrison MD, Joseph Kay MD, Roni M. Jacobsen MD, Camila Londono-Obregon MD, Elizabeth Yeung MD, Sarah L. Kelly PsyD, Ann Poteet NP MS, Claire Levek MS, Michael J. Landzberg MD, Molly Wallrich RN, Amber Khanna MD
Psychological trauma, symptoms of post-traumatic stress disorder (PTSD), and mental health conditions are common in adult congenital heart disease (ACHD). There is a gap in the literature examining PTSD in ACHD using the current DSM-5 criteria, while assessing patient characteristics and experiences with trauma-focused treatment. Surveys were offered to outpatients over a six-month enrollment period
-
Aortic Root Dimension using Transthoracic Echocardiography: Results from The Copenhagen City Heart Study Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-06 Maria W. Pedersen PhD, Kirsten Duch cand. Scient, Filip L Lindgren MD, Nils L.O. Lundgren MD, Bhupendar Tayal PhD, Andreas Hagendorff MD, Gorm B. Jensen DMSc, Tor Biering-Sørensen PhD, Peter Schnohr DMSc, Rasmus Møgelvang PhD, Nis Høst PhD, Kristian Kragholm PhD, Niels H. Andersen DMSc, Peter Søgaard DMSc
Findings regarding the relationship between aortic size and risk factors are heterogeneous. The present study aimed at generating new insights from a population-based adult cohort on aortic root dimensions and their association with age, anthropometric measures, and cardiac risk factors; and at evaluating the incidence of acute aortic events. Participants from the fifth examination round of the Copenhagen
-
Contribution of Peripheral Microvascular Dysfunction to Mild Cognitive Impairment Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-05 Matthew E. Gold MD, Steven C. Rogers MD PhD, Ambar Kulshreshtha MD PhD, Yuxuan Chen BS, Yi-An Ko PhD, Michael L. Cheng MD, Daniel A. Gold MD, Nishant Vatsa MD, Vardhmaan Jain MD, Shivang Desai MD, Kasra Moazzami MD MPH MSCR, Tiffany Thomas MS, Maureen Okafor MD MPH, Felicia Goldstein PhD, James Lah MD PhD, Arshed A. Quyyumi MD, Ihab Hajjar MD MPH
-
Associations between Metabolic Syndrome and Long-term Mortality in PCI patients: An Australian Cohort Analysis Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-04 Joseph M O'Brien MBBS, Diem Dinh BAppSc PhD, Louise Roberts BSc PhD, Andrew Teh MBBS PhD, Angela Brennan RN, Stephen J. Duffy MBBS PhD, David Clark MBBS DMedSci, Andrew Ajani MBBS MD, Ernesto Oqueli MD, Martin Sebastian MBBS, Christopher Reid BA DipEd MSc, Cert Health Econ PhD, Melanie Freeman MBBS, Jaya Chandrasekhar MBBS MS PhD, Melbourne Interventional Group
Metabolic syndrome (MetS) provides significant risk for coronary disease, however long-term prognosis after percutaneous coronary intervention (PCI) has been understudied. We assessed the prevalence and outcomes of patients with MetS from an Australian PCI cohort. We retrospectively examined data from the Melbourne Interventional Group multicentre PCI registry using a modified definition for MetS including
-
SYNERGY- Everolimus eluting stent with a bioabsorbable polymer in ST elevation myocardial infarction- CLEAR SYNERGY OASIS-9 Registry Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-04 Sanjit S. Jolly MD, Shun Fu Lee PhD, Rajibul Mian PhD, Sasko Kedev MD, Shahar Lavi MD, Raul Moreno MD, Gilles Montalescot MD, Ali Hillani MD, Timothy D. Henry MD, Valon Asani MD, Robert F. Storey MD, Johanne Silvain MD, James C.S. Spratt MD, Marc-André d'Entremont MD, Goran Stankovic MD, Biljana Zafirovska MD, Madhu K. Natarajan MD, Manel Sabate MD, Satya Shreenivas MD, Natalia Pinilla-Echeverri MD
Our objective was to evaluate the clinical effectiveness of the SYNERGY stent in patients with ST elevation myocardial infarction (STEMI). The only drug eluting stent approved for treatment of STEMI by the FDA is the Taxus stent which is no longer commercially available, so further data are needed. The CLEAR SYNERGY stent registry was embedded into a larger randomized trial of patients with STEMI (N=7000)
-
Sustainability of Blood Pressure Reduction Through Adapted Mindfulness Training: The MB-BP Study Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-04 Eric B. Loucks PhD, Vinicius V. Neves MD MSc, Virginia Cafferky BS, Matthew M. Scarpaci MPH, Ian M. Kronish MD MPH
-
Distal versus Proximal Radial Artery Access for Cardiac Catheterization: 1-year Outcomes Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-02 Karim Al-Azizi MD, Ghadi Moubarak MD, Chadi Dib MD, Sameh Sayfo MD, Molly Szerlip MD, Sibi Thomas DO, Sarah Hale BA, Johanna Van Zyl PhD, Richard M. Settele BS, Osniel Ramos Gonzalez BS, Stephanie J. Ventura BA, J. Michael DiMaio MD, Michael J. Mack MD, Srinivasa Potluri MD
PRA access for cardiac catheterization is safe but can jeopardize subsequent use of the artery due to occlusion. DRA access in the anatomical snuffbox preserves the RA but safety and potential detrimental effects on hand function are unknown. We aimed to assess hand function and complications post Distal radial artery (DRA) and Proximal radial artery (PRA).
-
Distal Vs. Proximal Radial Arterial Access For Percutaneous Coronary Angiography and Intervention: Updated Meta-Analysis Of Randomized Controlled Trials Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-02 Syed Hamza Mufarrih MD, Sajjad Haider MD, Nada Qaisar Qureshi MD, Mohammad Saud Khan MD, Mohammed Kazimuddin MD FACC, Muhammad Shoaib Akbar MD FACC, Sameer Saleem MD FACC, Syeda Aleena Mufarrih MD, MD, Avnish Tripathi MD MPH PhD FACC, Aniruddha Singh MD FACC, Mohammad Abdul Waheed MD FACC
Comparison of safety outcomes in patients undergoing coronary access for diagnostic/ therapeutic interventions via distal versus proximal transradial access. Note: Subgroup analysis is not detailed within this visual abstract. Continuous outcomes are reported using the Standard Mean Difference (SMD) to ensure the forest plots are clearly visible and interpretable. [Display omitted]
-
Etiologies and Impact of Exclusion Rates for Transcatheter Mitral and Tricuspid Valve Structural Heart Clinical Trials at a High Volume Quaternary Care Hospital Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-02 Lu Chen MD, Lin Wang MD MS, George Petrossian MD, Newell Robinson MD, William Chung MD, Matthew Henry MD, Dennis Mihalatos MD, Ruqiyya Bano MPH, Jonathan Weber MPH, Jaffar Khan MD, David J. Cohen, Andrew Berke MD, Ziad Ali MD DPhil, Omar K. Khalique MD
There are various devices under clinical investigation for transcatheter mitral valve intervention (TMVI) and tricuspid valve intervention (TTVI), but exclusion rates remain high. We aim to investigate exclusion rates for transcatheter mitral valve repair (TMVr), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve repair (TTVr) and transcatheter tricuspid valve replacement
-
Atrial Fibrillation Amplifies Heart Failure Risk in Anthracycline Treated Cancer Patients: Stacking Risk Factors in the Vulnerable Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-02 Leonard Ilkhanoff, Brett Atwater, Ana Barac
-
Transcatheter Intervention for Inoperable Tricuspid Surgical Prosthesis Dysfunction: Minimally Invasive Approach to Mitigate Heart Failure Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-02 Piotr Nikodem Rudziński MD PhD, Jan Henzel MD PhD, Adam Witkowski MD, Maciej Dąbrowski MD PhD, Zenon Huczek MD, Wojciech Wojakowski MD, Radosław Targoński MD PhD, Dariusz Jagielak MD PhD, Paweł Kralisz MD PhD, Marcin Demkow MD
What is the efficacy and safety of transcatheter tricuspid valve-in-valve implantation for patients with inoperable tricuspid surgical prosthesis dysfunction? Thirty-day mortality after greatly effective transcatheter treatment is 2 times less than the estimated surgical risk.
-
The Characteristics of Primary Retrograde Approach Selection for Native Coronary Chronic Occlusion with Short Occlusion Length from the Japanese CTO-PCI Expert Registry Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-01 Yusuke Ochiumi MD, Etsuo Tsuchikane MD PhD, Koichi Kishi MD, Hisayuki Okada MD PhD, Yoshiaki Ito MD, Yuji Oikawa MD, Ryohei Yoshikawa MD, Atsunori Okamura MD PhD, Hiroyuki Tanaka MD, Osamu Katoh MD
Although the coronary chronic total occlusion (CTO) crossing algorithm has been published, the characteristics associated with the first strategy selection for short-length lesions < 20 mm have been still debatable. This study sought to determine the characteristics associated with primary retrograde approach (PRA) for native CTO with short occlusion length in percutaneous coronary intervention (PCI)
-
Cardiovascular Outcomes With Empagliflozin and Dapagliflozin in Patients Without Diabetes Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-01 Sahib Singh MD, Aakash Garg MD, Udaya S Tantry PhD, Kevin Bliden MBA, Paul A Gurbel MD, Martha Gulati MDMS
While the cardiovascular (CV) benefits with sodium-glucose cotransporter-2 inhibitors (SGLT2i) in patients with diabetes mellitus (DM) are well known, their effects in patients without DM continue to be explored. We provide a meta-analysis of the available evidence. Online databases were searched for randomized controlled trials (RCTs) comparing SGLT2i to placebo/control in patients without DM. The
-
Asymptomatic Aortic Stenosis: From Risk Stratification to Treatment Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-01 Marko Banovic, Bernard Iung, Svetozar Putnik, Thabo Mahendiran, Marc Vanderheyden, Emanuele Barbato, Jozef Bartunek
Our understanding of the natural history of aortic stenosis has significantly increased over the last decade. There have been considerable advances in the diagnosis and risk stratification of patients with aortic stenosis, as well as in surgical and anesthetic techniques. In addition, transcatheter aortic valve replacement has established itself as a viable alternative to surgical management. Inevitably
-
Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-01 Hani Alturkmani, Barry Uretsky, Swetal Patel, Mu'nes Albadaineh, Omar Alqaisi, Malek Alaiwah, Michael Cross, Danish Abbasi, William Rollefson
Intravenous unfractionated heparin (UFH) is the most frequently used anticoagulant for percutaneous coronary intervention (PCI). Intravenous enoxaparin, a low-molecular weight heparin, has superior pharmacokinetic and pharmacodynamic properties compared with UFH. Multiple trials have shown enoxaparin to be safe and effective in PCI. However, there has not been a contemporary study evaluating its safety
-
Associations Between Visceral Fat, Abdominal Muscle, and Coronary Artery Calcification: A Cross-Sectional Analysis of the Multi-Ethnic Study of Atherosclerosis Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-01 Amier Haidar MD MPH, Preethi Srikanthan MD MS, Karol Watson MD PhD, Matthew Allison MD MPH, Richard Kronmal PhD, Tamara Horwich MD MS
The associations of body composition components, including muscle and adipose tissue, and markers of subclinical coronary artery disease are unclear. We examined the relation between abdominal computed tomography (CT)–derived measures of the area and density of fat and muscle with coronary artery calcification (CAC), using data from the Multi-Ethnic Study of Atherosclerosis (MESA). A total of 1,974
-
Low Muscle Mass by Preprocedural Computed Tomography Is Associated With Worse Short-Term Outcomes in Transcatheter Aortic Valve Replacement Recipients Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-01 Ian Persits DO, Saeid Mirzai DO, Kunaal S. Sarnaik BS, Maximilian C. Volk DO, James Yun MD PhD, Serge Harb MD, Rishi Puri MD PhD, Samir Kapadia MD, Amar Krishnaswamy MD, Po-Hao Chen MD MBA, Grant Reed MD, W. H. Wilson Tang MD
Low muscle mass (LMM) is associated with worse outcomes in various clinical situations. Traditional frailty markers have been used for preoperative risk stratification in patients who underwent transcatheter aortic valve replacement (TAVR). However, preoperative imaging provides an opportunity to directly quantify skeletal muscle mass to identify patients at higher risk of procedural complications
-
Association Between Atrial Fibrillation Symptoms and Clinical Outcomes: A Prospective Multicenter Registry Study Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-01 Sang Jun Lee MD, Junbeom Park MD PhD, Jin-Kyu Park MD PhD, Ki-Woon Kang MD PhD, Jaemin Shim MD PhD, Eue-Keun Choi MD PhD, Jun Kim MD PhD, Jin-Bae Kim MD PhD, Young Soo Lee MD PhD, Hyung Wook Park MD PhD, Boyoung Joung MD PhD
The presence of symptoms plays an important role in determining whether to focus on rhythm control or rate control when treating atrial fibrillation (AF). Previous comparative studies on the clinical outcomes of symptomatic and asymptomatic AF have yielded inconsistent results, and a link between AF symptoms and left atrial (LA) remodeling is not established. Patients selected from the COmparison study
-
Changes in Global Longitudinal Strain as a Predictor of Cardiotoxicity After Exposure to Carfilzomib Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-01 Ranbir Singh MD, Dylan Sperling MD, Anthony Delicce MD, Sophia Golec MD, Supreet Singh MD, Nicole Zatorski PhD, Solomon Bienstock MD, Sumeet Singh Mitter MD MSc, Stamatios Lerakis MD, Gagan D. Sahni MD
-
Percutaneous Coronary Intervention in Nonagenarians Presenting With an Acute Coronary Syndrome Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-29 G, j, i, n, , N, d, r, e, p, e, p, a, , M, D
-
Comprehensive Angiography-Derived Functional Assessment of Epicardial and Microvascular Coronary Disease. Correlation With Non-invasive Myocardial Stress Imaging Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-29 Francesco Della Mora MD, Leonardo Portolan MD, Dimitrios Terentes-Printzios MD PhD, Andrea Vicerè MD, Stefano Andreaggi MD, Marco Biasin MD, Gabriele Pesarini MD PhD, Domenico Tavella MD, Caterina Maffeis MD, Elvin Tafciu MD, Giovanni Benfari MD PhD, Dimitrios Oikonomou MD, Konstantia-Paraskevi Gkini MD, Domenico Galante MD, Konstantinos Tsioufis MD PhD, Charalambos Vlachopoulos MD PhD, Antonio Maria
Coronary angiography (CA) is poorly correlated with non-invasive myocardial stress imaging (NSI) and myocardial ischemia is often observed in patients with unobstructed coronary arteries. Moreover, the diagnostic performance of combined epicardial and microcirculatory angiography-derived physiological assessment and its correlation with NSI remains unknown. A total of 917 coronary vessels in 319 patients
-
The Conduit Conundrum: A Commentary on “Outcomes of Radial Artery Versus Saphenous Vein as a Second Conduit After Coronary Artery Bypass Grafting” Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-28 Raghav Chandra MD, Christopher A. Heid MD
-
Hybrid Coronary Revascularization: Has Everything Clearly Described? Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-28 Erdi Babayiğit MD, Bülent Görenek MD
-
Comparison of the Diagnostic Yield of Intracoronary Acetylcholine Infusion and Acetylcholine Bolus Injection Protocols During Invasive Coronary Function Testing Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-28 Janneke Woudstra MD, Rutger G.T. Feenstra MD, Caitlin E.M. Vink MD, Koen M.J. Marques MD PhD, Coen K.M. Boerhout MD, Elize A.M. de Jong MSc, Guus A. de Waard MD PhD, Tim P. van de Hoef MD PhD, Steven A.J. Chamuleau MD PhD, Etto C. Eringa PhD, Jan J. Piek MD PhD, Yolande Appelman MD PhD, Marcel A.M. Beijk MD PhD
Coronary endothelial dysfunction (CED) and coronary artery spasm (CAS) are causes of angina with no obstructive coronary arteries in patients. Both can be diagnosed by invasive coronary function testing (ICFT) using acetylcholine (ACh). This study aimed to evaluate the diagnostic yield of a 3-minute ACh infusion as compared with a 1-minute ACh bolus injection protocol in testing CED and CAS. We evaluated
-
Emotional Distress (ED) & Clinical Outcomes in Cardiac Patients: Cause, Effect, or Confound? Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-27 M, a, r, k, , W, ., , K, e, t, t, e, r, e, r, , P, h, D, , A, B, P, P
-
The Role of Gender in Revascularization Strategies for Acute Coronary Syndrome and Multivessel Disease Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-26 Patrick Horn MD, Jafer Haschemi MD, Malte Kelm MD
-
Disparities in US Healthcare—A National Problem Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-26 J, o, s, e, p, h, , S, ., , A, l, p, e, r, t, , M, D
-
Multipoint Pacing for Cardiac Resynchronization: Is the MPP Juice Worth the Battery Squeeze? Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-25 Wissam Mekary MD, Faisal M. Merchant MD
-
Prophylactic Anticoagulation to Prevent Left Ventricular Thrombus Following Acute Myocardial Infarction: A Systematic Review and Meta-Analysis Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-25 Ethan Sacoransky BSc, Danny Yu Jia Ke BSc, Bryce Alexander BSc MD, Wael Abuzeid MSc MD
Clinical practice guidelines from the American Heart Association recommend consideration of prophylactic anticoagulation to prevent left ventricular thrombus (LVT) formation in patients with anterior ST-elevation myocardial infarction. These guidelines were given a low certainty of evidence (class IIb, level C), relying primarily on case studies and expert consensus to inform practice. Our objective
-
Traditional and Advanced Echocardiographic Evaluation in Chronic Obstructive Pulmonary Disease: The Forgotten Relation Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-25 Mihail Celeski MD, Andrea Segreti MD, Dajana Polito MD, Daniele Valente MD, Luisa Vicchio MD, Giuseppe Di Gioia MD, Gian Paolo Ussia MD, Raffaele Antonelli Incalzi MD, Francesco Grigioni PhD
Chronic obstructive pulmonary disease (COPD) is a significant preventable and treatable clinical disorder defined by a persistent, typically progressive airflow obstruction. This disease has a significant negative impact on mortality and morbidity worldwide. However, the complex interaction between the heart and lungs is usually underestimated, necessitating more attention to improve clinical outcomes
-
Renal Dysfunction and Outcomes in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-24 Yousaf Abughofah BS, Wesley L. Anderson MD, Rolf P. Kreutz MD
-
Do False Tendons Prevent Adverse Left Ventricular Remodeling After Anterior Wall Myocardial Infarction? An Echocardiographic Strain Imaging Study Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-24 Jeffrey J. Silbiger MD, Sanjin Tunovic MD, Huazhen Chen MD, Mazullah Kamran MD, Imad Bagh MD, Aditya Parikh MD, David Minsky RDCS
The role of muscular left ventricular (LV) false tendons (FTs) is poorly understood. To gain insight into their pathophysiologic significance, we adapted echocardiographic LV strain imaging software to measure LVFT longitudinal strain in subjects with normal left ventricles and in patients who sustained previous anterior wall myocardial infarction (AWMI). GE EchoPAC software was used to measure longitudinal
-
Intracardiac Versus Transesophageal Echocardiography Guided Percutaneous Debulking of Tricuspid Endocarditis Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-23 Robert S. Zhang MD, Eric Bailey MD, Muhammad H. Maqsood MD, Rafael Harari MD, Samuel Bernard MD, Yuhe Xia MS, Norma Keller MD, Carlos L. Alviar MD, Sripal Bangalore MD MHA
-
How Do the Flow Components of Coronary Flow Reserve Change After Aortic Valve Replacement? Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-23 Rob Eerdekens MD MSc, H.V. ("Skip") Anderson MD, Nils P. Johnson MD MS
-
Cerebral Embolic Protection in Valve-in-Valve Transcatheter Aortic Valve Replacement Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-23 Shashank Shekhar MD, Amar Krishnaswamy MD, Grant Reed MD MSc, Rishi Puri MD PhD, James Yun MD, Samir Kapadia MD
-
The Chronic Dilemma of Chronic Total Occlusion Revascularization Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-23 Salvatore Cassese MD PhD, Adnan Kastrati MD
-
Real-World Comparison of Clopidogrel With Ticagrelor and Prasugrel in Patients With Chronic Coronary Disease Who Underwent Atherectomy Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-23 Mahin R. Khan MD, Anoop N. Koshy MD PhD, Richard Tanner MBBCh, Serdar Farhan MD, Manish Vinayak MD, Ali Farooq MD, Samantha Sartori PhD, Yihan Feng MS, Alessandro Spirito MD, Ayush Arora MD, Vishal Dhulipala MD, Vishal Kapur MD, Javed Suleman MD, Raman Sharma MD, Roxana Mehran MD, Annapoorna Kini MD, Samin K. Sharma MD
-
Sex-Related Outcomes of Transcatheter Aortic Valve Implantation With Self-Expanding or Balloon-Expandable Valves: Insights from the OPERA-TAVI Registry Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-23 Marianna Adamo, Luca Branca, Elisa Pezzola, Francesco Saia, Thomas Pilgrim, Mohamed Abdel-Wahab, Philippe Garot, Caterina Gandolfo, Claudia Fiorina, Sofia Sammartino, Azeem Latib, Ignacio Amat Santos, Darren Mylotte, Federico De Marco, Ole De Backer, Luis Nombela Franco, Mariama Akodad, Flavio Luciano Ribichini, Francesco Bedogni, Giulia Laterra, Alessandro Mazzapicchi, Daijiro Tomii, Pietro Laforgia
Evidence regarding sex-related differences in response to transcatheter aortic valve implantation according to the valve type is lacking. This study sought to evaluate the impact of sex on the treatment effect of Evolut-PRO/PRO+ (PRO) or Sapien 3 Ultra (ULTRA) devices on clinical outcomes. Comparative Analysis of Evolut PRO vs Sapien 3 Ultra Valves for Transfemoral Transcatheter Aortic Valve Implantation
-
Long Term Outcomes of Pharmacoinvasive Strategy vs. Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction: A Study From Mexico City Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-23 Alexandra Arias-Mendoza, Rodrigo Gopar-Nieto, Jessica Juarez-Tolen, Juan Carlos Ordóñez-Olvera, Héctor Gonzalez-Pacheco, Jose Luis Briseño-De la Cruz, Daniel Sierra-Lara Martinez, Salvador Mendoza-García, Alfredo Altamirano-Castillo, Alvaro Montañez-Orozco, Arturo Arzate Ramirez, Luis A. Baeza-Herrera, Jorge A Ortega-Hernandez, Greta Miranda-Cerda, Jesus Erick Cruz-Martinez, Francisco Martin Baranda-Tovar
While primary percutaneous coronary intervention (pPCI) is the treatment of choice in ST elevation myocardial infarction (STEMI), challenges may arise in accessing this intervention for certain geodemographic groups. Pharmacoinvasive strategy (PIs) has demonstrated comparable outcomes when delays in pPCI are anticipated, but real-world data on long-term outcomes are limited. The aim of the present
-
Prognostic Impact of Previous Atherosclerotic Cardiovascular Disease on Short- and Long-Term Outcomes in Acute Myocardial Infarction Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-23 Yuichi Saito MD, Hiroaki Yaginuma MD, Kazunari Asada MD, Hiroki Goto MD, Takanori Sato MD, Hideki Kitahara MD, Yoshio Kobayashi MD
Patients with previous atherosclerotic cardiovascular disease (ASCVD) are typically managed by secondary prevention modalities; however, they may experience recurrent events. In acute myocardial infarction (MI), the prognostic effect of preexisting ASCVD on the short- and long-term outcomes remains uncertain. This retrospective, multicenter registry included 2,475 patients with acute MI who underwent
-
Comparative Evaluation of Alcohol Septal Ablation: Left Anterior Descending Versus Non-left Anterior Descending Artery Approaches Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-23 Yoshihiro Harano, Yuki Sahashi, Yoshiaki Kawase, Hitoshi Matsuo
Alcohol septal ablation (ASA) is performed for symptomatic drug-refractory hypertrophic obstructive cardiomyopathy to reduce the left ventricular outflow tract pressure gradient (LVOTPG) by injecting ethanol into a septal branch that perforates the septal bulge. The target septal branches usually arise directly from the left anterior descending (LAD) artery; however, vessels from a non-LAD artery can
-
Classification of the Urgency of the Procedure and Outcome of Acute Type A Aortic Dissection Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-23 Fausto Biancari MD PhD, Angelo M. Dell'Aquila MD PhD, Francesco Onorati MD PhD, Cecilia Rossetti MD, Till Demal MD, Andreas Rukosujew MD, Sven Peterss MD, Joscha Buech MD, Antonio Fiore MD, Thierry Folliguet MD, Andrea Perrotti MD PhD, Amélie Hervé MD, Francesco Nappi MD, Lenard Conradi MD, Angel G. Pinto MD, Javier Rodriguez Lega MD, Marek Pol MD, Petr Kacer MD, Konrad Wisniewski MD, Enzo Mazzaro
Surgery for type A aortic dissection (TAAD) is associated with a high risk of early mortality. The prognostic impact of a new classification of the urgency of the procedure was evaluated in this multicenter cohort study.
-
Prolonged Dual Antiplatelet Therapy in Acute Myocardial Infarction Patients Without Revascularization: China Acute Myocardial Infarction Registry Study Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-23 Cunrong Huang MSc, Jingang Yang MD, Ling Li MB, Shenghu He MD, Xuxia Zhang MD, Haiyan Xu MD, Yuan Wu MD, Jun Zhang MD, Shubin Qiao MD, Yongjian Wu MD, Yanyan Zhao PhD, Yang Wang PhD, Wei Li PhD, Chen Jin MSc, Xiaojin Gao MD, Yuejin Yang MD, CAMI (China Acute Myocardial Infarction) Registry study group
At least 12 months of dual antiplatelet therapy (DAPT) is 1 of the standards of care following percutaneous coronary intervention in patients with acute coronary syndrome. However, study on prolonged DAPT for patients with acute myocardial infarction (AMI) without revascularization is limited. We studied 1,744 patients with AMI without revascularization from the China Acute Myocardial Infarction registry
-
-
-
Impact of Age, Gender, and Body Mass Index on Short-Term Outcomes of Patients With Cardiogenic Shock on Mechanical Circulatory Support Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-20 Raunak M. Nair MD, Sachin Kumar MD, Talha Saleem MD, Ran Lee MD, Andrew Higgins MD, Umesh N. Khot MD, Grant W. Reed MD MSc, Venu Menon MD
This single-center, observational study assessed the impact of age, gender, and body mass index (BMI) in patients with cardiogenic shock (CS) on temporary mechanical circulatory support.
-
Racial Differences in Hospice Care Outcomes in Patients With Advanced Heart Failure: Systematic Review and Meta-analysis Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-20 Diego Chambergo-Michilot MD, Victor G. Becerra-Gonzales MD, Veraprapas Kittipibul MD, Rosario Colombo MD, Katia Bravo-Jaimes MD
There remains a paucity of investigational data about disparities in hospice services in people with non-cancer diagnoses, specifically in heart failure (HF). Black patients with advanced HF have been disproportionally affected by health care services inequities but their outcomes after hospice enrollment are not well studied. We aimed to describe race-specific outcomes in patients with advanced HF
-
Cardiovascular Health, Lifestyle Factors, and Social Determinants in Asian Subpopulations in the United States Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-17 Sudheesha Perera MPH, ZhaoNian Zheng MSc, Rishi K. Wadhera MD MPP MPhil
Asian Americans are often aggregated in national public health surveillance efforts, which may conceal important differences in the health status of subgroups that are included in this highly diverse population. Little is known about how cardiovascular health varies across Asian subpopulations and the extent to which lifestyle and social risk factors contribute to any observed differences. This national
-
The Effect of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Patients With Cancer: A Systematic Review and Meta-Analysis Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-17 Siddharth Agarwal MD, Usama Qamar MD, Yu Fujiwara MD, Avirup Guha MD MPH, Abdul Rafeh Naqash MD, Eric H. Yang MD, Daniel Addison MD, Ana Barac MD PhD, Zain Ul Abideen Asad MD MS
-
Low Incidence of New Intracranial Aneurysms in Adults with Coarctation of Aorta on Serial Brain Imaging Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-17 Alexander C. Egbe, William R. Miranda, C. Charles Jain, Luke J. Burchill, Maan Jokhadar, Robert D. Brown, Heidi M. Connolly
-
The End of a Controversy: The Rise, Fall, and Redemption of Paclitaxel-Coated Devices Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-17 Eric A. Secemsky, Robert W. Yeh, Peter A. Schneider, William Gray, Sahil Parikh